Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort

28, Jan 2026

2
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Role of Rare Genetic Variants in Multiple Sclerosis Pathogenesis

27, Jan 2026

3
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis
Genetics
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis

26, Jan 2026

4
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk

25, Jan 2026

5
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis
Genetics
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis

23, Jan 2026

Categories:
Genetics
Could Our Genes Hold the Key to Safer MS Treatments? Exploring the Promise of Pharmacogenomics
Genetics
Could Our Genes Hold the Key to Safer MS Treatments? Exploring the Promise of Pharmacogenomics

03, Apr 2025

Personalized MS Treatment: Will Our Genes Lead the Way?
Genetics
Personalized MS Treatment: Will Our Genes Lead the Way?

05, Apr 2025

Decoding MS Treatment: Can Our Genes Predict How We'll Respond to Interferon-beta?
Genetics
Decoding MS Treatment: Can Our Genes Predict How We'll Respond to Interferon-beta?

06, Apr 2025

Decoding MS Treatment Response: A Look at the Pharmacogenomics of Interferon-Beta and Glatiramer Acetate
Genetics
Decoding MS Treatment Response: A Look at the Pharmacogenomics of Interferon-Beta and Glatiramer Acetate

07, Apr 2025